Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Esophageal Neoplasms 12Esophageal Squamous Cell Carcinoma 7Carcinoma, Non-Small-Cell Lung 6Rectal Neoplasms 5Uterine Cervical Neoplasms 4Pancreatic Neoplasms 4Head and Neck Neoplasms 3Glioblastoma 3Brain Neoplasms 3Stomach Neoplasms 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Hyperthermia 2Anus Neoplasms 2Adenocarcinoma 2Unresectable Stage III NSCLC 1Thymic epithelial tumor 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Recurrence 1Rare Diseases 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1Neoplasm Metastasis 1Mucositis 1Metastasising Cancer of Unknown Primary 1Medulloblastoma 1Lymphoma, B-Cell, Marginal Zone 1Locally Advanced Rectal Cancer 1

Interventions

Surveys and Questionnaires 1Restraint, Physical 1Radiosurgery 1Radiation 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Genetic Diseases, Inborn × Radiation × Clear all
NCT00004659 2005-06-24

Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors

Office of Rare Diseases (ORD)

Phase 2 Unknown
40 enrolled
CNS

Brain Neoplasms, Genetic Diseases, Inborn, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡